Serum Fibroblast Growth Factor 21 Level Is Associated with Aortic Stiffness in Patients on Maintenance Hemodialysis
Background. Fibroblast growth factor 21 (FGF-21) is a hormone that regulates glucose and lipid metabolism. High serum FGF-21 levels are associated with carotid atherosclerosis and coronary artery disease. This cross-sectional study aimed to assess the relationship between serum FGF-21 levels and car...
Saved in:
| Main Authors: | Liang-Te Chiu, Chi-Di Hung, Lin Lin, Yu-Li Lin, Bang-Gee Hsu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | International Journal of Hypertension |
| Online Access: | http://dx.doi.org/10.1155/2022/7098458 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Serum resistin as an independent marker of aortic stiffness in patients with coronary artery disease.
by: Ji-Hung Wang, et al.
Published: (2017-01-01) -
High serum leptin levels are associated with central arterial stiffness in geriatric patients on hemodialysis
by: Chiu-Huang Kuo, et al.
Published: (2018-01-01) -
The correlation between serum fibroblast growth factor 19 and vascular calcification in maintenance hemodialysis patients
by: Yao Dan-dan, et al.
Published: (2025-06-01) -
Serum osteopontin level is independently associated with arterial stiffness in patients on hemodialysis
by: Po-Yu Huang, et al.
Published: (2025-04-01) -
Serum Irisin Level Is Positively Associated with Bone Mineral Density in Patients on Maintenance Hemodialysis
by: Chia-Wen Lu, et al.
Published: (2021-01-01)